MOLECULAR-STRUCTURE ANALYSIS OF THE PITUITARY ADENYLATE-CYCLASE ACTIVATING POLYPEPTIDE TYPE-I RECEPTOR FROM PIG BRAIN

被引:12
|
作者
CAO, YJ [1 ]
GIMPL, G [1 ]
FAHRENHOLZ, F [1 ]
机构
[1] MAX PLANCK INST BIOPHYS,D-60596 FRANKFURT,GERMANY
来源
关键词
PACAP RECEPTOR; PIG BRAIN; SOLUBILIZATION; DEGLYCOSYLATION; DESIALYLATION; SULFHYDRYL GROUP;
D O I
10.1016/0167-4889(94)90051-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In pig brain a type I receptor for pituitary adenylate cyclase activating polypeptide (PACAP) has been identified and structurally characterized. Scatchard analysis of the equilibrium binding data indicates a single class of binding sites with K, of 0.50 nM and B-max of 2.52 pmol/mg. The receptors could be efficiently solubilized with 3-[(3-cholamidopropyl)dimethylammonio]-2-hydroxy- 1-propanesulfonate (Chapso) without altering their ligand binding parameters (K-d = 0.60 nM; B-max = 2.46 pmol/mg). In both preparations the ligand receptor complex was identified as a 68 kDa polypeptide by affinity crosslinking with I-125-PACAP-27 and disuccinimidyl suberate. Employment of nonreducing conditions decreased the electrophoretic mobility of the complex to a 60 kDa species suggesting that the native PACAP receptor exists in a compact conformation stabilized by intramolecular disulfide bridges. Disulfide bonds are also important for the ligand binding activity of the PACAP receptor since pretreatment of the membranes with dithiothreitol led to complete inhibition of PACAP binding and to 61% dissociation of the ligand-receptor complex. Among different sulfhydryl selective reagents tested, p-chloromercuriphenylsulfonic acid was found to inhibit PACAP binding to its receptor in a dose-dependent fashion (IC50 = 0.5 mM) suggesting that one or more sulfhydryl groups are located close to the ligand binding domain of the receptor. Desialylation of the affinity-labeled PACAP receptor with neuraminidase revealed a 61 kDa protein, whereas deglycosylation with N-glycosidase F decreased the M(r) to 52000. Chromatography on a series of lectin agaroses showed the highest affinity for wheat germ agglutinin (WGA). WGA was also effective in dose-dependent inhibition of PACAP binding activity. Our results characterize the pig PACAP receptor as a tri- or tetraantennary non- or low fucosylated complex type glycoprotein with a protein core of about 49 kDa containing several terminal sialyl residues.
引用
收藏
页码:432 / 440
页数:9
相关论文
共 50 条
  • [1] SOLUBILIZATION OF RECEPTOR FOR PITUITARY ADENYLATE-CYCLASE ACTIVATING POLYPEPTIDE FROM BOVINE BRAIN
    MASUDA, Y
    OHTAKI, T
    KITADA, C
    TSUDA, M
    ARIMURA, A
    FUJINO, M
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1990, 172 (02) : 709 - 714
  • [2] MOLECULAR-IDENTIFICATION OF RECEPTOR FOR PITUITARY ADENYLATE-CYCLASE ACTIVATING POLYPEPTIDE
    OHTAKI, T
    WATANABE, T
    ISHIBASHI, Y
    KITADA, C
    TSUDA, M
    GOTTSCHALL, PE
    ARIMURA, A
    FUJINO, M
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1990, 171 (02) : 838 - 844
  • [3] Distribution of pituitary adenylate cyclase-activating polypeptide and pituitary adenylate cyclase-activating polypeptide type I receptor mRNA in the chicken brain
    Peeters, K
    Gerets, HHJ
    Arckens, L
    Vandesande, F
    JOURNAL OF COMPARATIVE NEUROLOGY, 2000, 423 (01) : 66 - 82
  • [4] MOLECULAR-CLONING AND FUNCTIONAL EXPRESSION OF THE PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE TYPE-I RECEPTOR
    PISEGNA, JR
    WANK, SA
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (13) : 6345 - 6349
  • [5] CLONING OF A SPLICE VARIANT OF THE PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE (PACAP) TYPE-I RECEPTOR
    SVOBODA, M
    TASTENOY, M
    CICCARELLI, E
    STIEVENART, M
    CHRISTOPHE, J
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 195 (02) : 881 - 888
  • [6] FRAGMENTS OF PITUITARY ADENYLATE-CYCLASE ACTIVATING POLYPEPTIDE DISCRIMINATE BETWEEN TYPE-I AND TYPE-II RECOMBINANT RECEPTORS
    GOURLET, P
    VANDERMEERS, A
    VANDERMEERSPIRET, MC
    RATHE, J
    DENEEF, P
    ROBBERECHT, P
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1995, 287 (01) : 7 - 11
  • [7] STRUCTURE OF THE HUMAN PITUITARY ADENYLATE-CYCLASE ACTIVATING POLYPEPTIDE (PACAP) GENE
    HOSOYA, M
    KIMURA, C
    OGI, K
    OHKUBO, S
    MIYAMOTO, Y
    KUGOH, H
    SHIMIZU, M
    ONDA, H
    OSHIMURA, M
    ARIMURA, A
    FUJINO, M
    BIOCHIMICA ET BIOPHYSICA ACTA, 1992, 1129 (02) : 199 - 206
  • [8] CONCENTRATIONS OF PITUITARY ADENYLATE-CYCLASE ACTIVATING POLYPEPTIDE (PACAP) IN HUMAN BRAIN NUCLEI
    PALKOVITS, M
    SOMOGYVARIVIGH, A
    ARIMURA, A
    BRAIN RESEARCH, 1995, 699 (01) : 116 - 120
  • [9] Ocular expression of type-I pituitary adenylate cyclase-activating polypeptide (PACAP) receptors
    Cavallaro, S
    DAgata, V
    Drago, F
    Musco, S
    Nuciforo, G
    Ricciardolo, F
    Travali, S
    Stivala, F
    Arimura, A
    Canonico, PL
    VIP, PACAP, AND RELATED PEPTIDES, 2ND INTERNATIONAL SYMPOSIUM, 1996, 805 : 555 - 557
  • [10] PASSAGE OF PITUITARY ADENYLATE-CYCLASE ACTIVATING POLYPEPTIDE(1-27) AND PITUITARY ADENYLATE-CYCLASE ACTIVATING POLYPEPTIDE(1-38) ACROSS THE BLOOD-BRAIN-BARRIER
    BANKS, WA
    KASTIN, AJ
    KOMAKI, G
    ARIMURA, A
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1993, 267 (02): : 690 - 696